Active

Contract Opportunity

Procurement Technical Assistance Centers (PTACs) are an official government contracting resource for small businesses. Find your local PTAC (opens in new window) for free government expertise related to contract opportunities.

INTRODUCTION

PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT TO ACTION.

THIS IS A PRE-SOLICITATION NON-COMPETITIVE NOTICE OF INTENT TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA) at the National Insitutes of Health (NIH) on behalf of the National Center for Advancing Translational Sciences (NCATS) intends to negotiate and award a purchase order for Promega Reagents for NCATS ETB to: Promega Corporation, 2800 Woods Hollow Rd., Fitchburg, WI 53711-5300. NCATS’ screening assays have been optimized using Promega reagents. As these projects use these reagents from Promega as a control in NCATS’ science, introducing alternative reagents at this point would cause immense cost and time restraints to the government, based on re-optimizing all screens before moving forward. Additionally, utilizing alternatives would jeopardize scientific continuity of ongoing data and research.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 325413, In-Vitro Diagnostic Substance Manufacturing, with a Size Standard of 1,250 employees.

REGULATORY AUTHORITY

The resultant contract will include all applicable provisions and clauses of the Federal acquisition Requlation (FAR) currently in effect at https://www.acquisition.gov/

STATUTORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures.

DESCRIPTION OF REQUIREMENT

Project Description

See Attachment 1 – Purchase Description.

Purpose and Objectives

The purpose of this procurement is the acquisition of Promega reagent kits and assays for the Antiviral Program for Pandemics at the National Center for Advancing Translational Sciences (NCATS).

Delivery Date

Within thirty (35) calendar days after receipt of order (ARO).

CLOSING STATEMENT

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice.

Responses to this Notice must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement.

In addition the Unique Entity Identifier (UEI), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses must be received by 09:00 AM EDT June 12, 2023. Responses must be emailed to the Contracting Officer at mark.mcnally@nih.gov and reference the Notice ID 75N95023Q00392.

“All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.”

Attachments/Links